Treatment of Mild, Moderate, and Severe Onychomycosis Using 870- and 930-nm Light Exposure
Journal of the American Podiatric Medical Association2010Vol. 100(3), pp. 166–177
Citations Over TimeTop 10% of 2010 papers
Adam S. Landsman, Alan H. Robbins, Paula F Angelini, Catherine C Wu, Jeremy J. Cook, Mary E. Oster, Eric Bornstein
Abstract
These results indicate a role for this laser in the treatment of onychomycosis, regardless of degree of severity. Ease of delivery and the lack of a need to monitor blood chemistry are attractive attributes.
Related Papers
- → Drug-Induced Photosensitivity: Clinical Types of Phototoxicity and Photoallergy and Pathogenetic Mechanisms(2022)40 cited
- → Changes in the dermoscopic appearance of melanocytic naevi after photochemotherapy or narrow‐band ultraviolet B phototherapy(2007)20 cited
- → Ultraviolet Corneal Photoablation(2002)20 cited
- → Corneal Photoablation by Far Ultraviolet Lasers(1987)2 cited
- Comparison of the efficacy of psoralen ultraviolet A (PUVA) and narrow-band ultraviolet B (NBUVB) in the treatment of patients with vitiligo: A clinical trial(2017)